January 30, 2018 / 1:15 PM / 4 months ago

BRIEF-Bracco Diagnostics Receives FDA Approval For Use Of Multihance Injection In Patients Younger Than 2

Jan 30 (Reuters) - Bracco Diagnostics Inc:

* BRACCO DIAGNOSTICS INC. RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR USE OF MULTIHANCE® (GADOBENATE DIMEGLUMINE) INJECTION, 529 MG/ML IN MAGNETIC RESONANCE IMAGING (MRI) OF THE CENTRAL NERVOUS SYSTEM (CNS) IN PEDIATRIC PATIENTS YOUNGER TH Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below